Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""BONE density"" wg kryterium: Temat


Starter badań:

Tytuł :
[German Society of Rheumatology Recommendations for the management of glucocorticoid-induced Osteoporosis. German version].
Autorzy :
Leipe J; Sektion Rheumatologie, Medizinische Klinik V, Universitätskrankenhaus Mannheim, Universitätsklinikum Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland. .; Sektion Rheumatologie und Klinische Immunologie, Medizinische Klinik IV, Ludwig-Maximilians-Universität München, München, Deutschland. .
Holle JU; Rheumazentrum Schleswig-Holstein Mitte, Neumünster, Deutschland.
Weseloh C; Deutsche Gesellschaft für Rheumatologie, Berlin, Deutschland.
Pfeil A; Klinik für Innere Medizin III, Funktionsbereich Rheumatologie, Universitätsklinikum Jena, Jena, Deutschland.
Krüger K; Rheumatologisches Praxiszentrum München, München, Deutschland.
Pokaż więcej
Transliterated Title :
Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Management der Glukokortikoid-induzierten Osteoporose.
Corporate Authors :
die Kommission Pharmakotherapie der Deutschen Gesellschaft für Rheumatologie e. V. (DGRh)
Źródło :
Zeitschrift fur Rheumatologie [Z Rheumatol] 2021 Sep; Vol. 80 (7), pp. 670-687. Date of Electronic Publication: 2021 Aug 06.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/chemically induced
Osteoporosis*/drug therapy
Osteoporosis*/prevention & control
Rheumatology*
Adult ; Bone Density ; Diphosphonates ; Glucocorticoids/adverse effects ; Humans
Czasopismo naukowe
Tytuł :
A novel effervescent formulation of oral weekly alendronate (70 mg) improves persistence compared to alendronate tablets in post-menopausal women with osteoporosis.
Autorzy :
Giusti A; Rheumatology Unit, Department of Musculoskeletal System, Local Health Trust 3, Via Missolungi 14, 16147, Genoa, Italy. .
Bianchi G; Rheumatology Unit, Department of Musculoskeletal System, Local Health Trust 3, Via Missolungi 14, 16147, Genoa, Italy.
Barone A; Orthogeriatric Unit, Department of Geriatric Care, Orthogeriatrics and Rehabilitation, E.O. Galliera Hospital, Genova, Italy.
Black DM; Department of Epidemiology & Biostatistics, University of California, San Francisco, CA, USA.
Pokaż więcej
Źródło :
Aging clinical and experimental research [Aging Clin Exp Res] 2021 Sep; Vol. 33 (9), pp. 2529-2537. Date of Electronic Publication: 2021 Jan 15.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/adverse effects
Osteoporosis*
Osteoporosis, Postmenopausal*/drug therapy
Alendronate/adverse effects ; Bone Density ; Female ; Humans ; Postmenopause ; Tablets
Czasopismo naukowe
Tytuł :
Switching to Denosumab or Bisphosphonates After Completion of Teriparatide Treatment in Women With Severe Postmenopausal Osteoporosis.
Autorzy :
Kocjan T; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. Electronic address: .
Rajic AS; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Janez A; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Vidmar G; Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; University Rehabilitation Institute, Ljubljana, Slovenia; Department of Psychology, Faculty of Mathematics, Natural Sciences and Information Technologies, University of Primorska, Koper, Slovenia.
Orehek N; Chair of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Marc J; Chair of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Ostanek B; Chair of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Pokaż więcej
Źródło :
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2021 Sep; Vol. 27 (9), pp. 941-947. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Denosumab*/therapeutic use
Diphosphonates*/therapeutic use
Osteoporosis, Postmenopausal*/drug therapy
Aged ; Bone Density ; Drug Substitution ; Female ; Humans ; Retrospective Studies ; Teriparatide/therapeutic use
Czasopismo naukowe
Tytuł :
Effects of anti-resorptive treatment on the material properties of individual canine trabeculae in cyclic tensile tests.
Autorzy :
Frank M; Institute of Lightweight Design and Structural Biomechanics, TU Wien, Gumpendorfer Straße 7, 1060 Vienna, Austria. Electronic address: .
Grabos A; Institute of Lightweight Design and Structural Biomechanics, TU Wien, Gumpendorfer Straße 7, 1060 Vienna, Austria; Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, 340 West 10th Street Fairbanks Hall, Suite 6200, Indianapolis, USA.
Reisinger AG; Department of Anatomy and Biomechanics, Division Biomechanics, Karl Landsteiner University of Health Sciences, Dr.-Karl-Dorrek-Straße 30, 3500 Krems an der Donau, Austria. Electronic address: .
Burr DB; Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, 340 West 10th Street Fairbanks Hall, Suite 6200, Indianapolis, USA. Electronic address: .
Pahr DH; Institute of Lightweight Design and Structural Biomechanics, TU Wien, Gumpendorfer Straße 7, 1060 Vienna, Austria; Department of Anatomy and Biomechanics, Division Biomechanics, Karl Landsteiner University of Health Sciences, Dr.-Karl-Dorrek-Straße 30, 3500 Krems an der Donau, Austria. Electronic address: .
Allen MR; Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, 340 West 10th Street Fairbanks Hall, Suite 6200, Indianapolis, USA. Electronic address: .
Thurner PJ; Institute of Lightweight Design and Structural Biomechanics, TU Wien, Gumpendorfer Straße 7, 1060 Vienna, Austria. Electronic address: .
Pokaż więcej
Źródło :
Bone [Bone] 2021 Sep; Vol. 150, pp. 115995. Date of Electronic Publication: 2021 May 01.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Alendronate*/pharmacology
Bone Density Conservation Agents*/pharmacology
Animals ; Biomechanical Phenomena ; Bone Density ; Diphosphonates/pharmacology ; Dogs
Czasopismo naukowe
Tytuł :
Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study.
Autorzy :
McCloskey EV; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. .; Centre for Integrated Research in Musculoskeletal Ageing (CIMA), Mellanby Centre for Bone Research, University of Sheffield, Sheffield, UK. .; Metabolic Bone Centre, Northern General Hospital, Herries Road, Sheffield, S5 7AU, UK. .
Johansson H; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.; Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
Harvey NC; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Lorentzon M; Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.; Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, Geriatric Medicine, Sahlgrenska University Hospital, Mölndal, Sweden.
Shi Y; Amgen Inc, Thousand Oaks, CA, USA.
Kanis JA; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Pokaż więcej
Źródło :
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2021 Aug; Vol. 32 (8), pp. 1601-1608. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Osteoporosis, Postmenopausal*/complications
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis, Postmenopausal*/epidemiology
Osteoporotic Fractures*/epidemiology
Osteoporotic Fractures*/etiology
Osteoporotic Fractures*/prevention & control
Antibodies, Monoclonal ; Bone Density ; Female ; Humans ; Risk Assessment ; Risk Factors
Czasopismo naukowe
Tytuł :
Bone Mineral Densitometry Reporting: Pearls and Pitfalls.
Autorzy :
Martineau P; Department of Radiology, 12359University of Manitoba, Winnipeg, Manitoba, Canada.
Morgan SL; Department of Medicine, 9968University of Alabama, Birmingham, Alabama, USA.
Leslie WD; Department of Medicine, 12359University of Manitoba, Winnipeg, Manitoba, Canada.
Pokaż więcej
Źródło :
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes [Can Assoc Radiol J] 2021 Aug; Vol. 72 (3), pp. 490-504. Date of Electronic Publication: 2020 Apr 20.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Bone Density*
Absorptiometry, Photon/*standards
Osteoporosis/*diagnostic imaging
Bone Density Conservation Agents/therapeutic use ; Contrast Media ; Denosumab/adverse effects ; Diagnostic Errors ; Femoral Fractures/chemically induced ; Femoral Fractures/diagnostic imaging ; Femur Neck/diagnostic imaging ; Humans ; Movement ; Osteitis Deformans/complications ; Osteitis Deformans/diagnostic imaging ; Osteoarthritis/complications ; Osteoarthritis/diagnostic imaging ; Osteoporosis/complications ; Osteoporosis/drug therapy ; Patient Positioning ; Radioisotopes ; Spine/diagnostic imaging
Czasopismo naukowe
Tytuł :
Denosumab in chronic kidney disease: a narrative review of treatment efficacy and safety.
Autorzy :
Gopaul A; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Kanagalingam T; Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Thain J; Division of Geriatrics, Western University, London, ON, Canada.
Khan T; Division of Endocrinology and Metabolism, Western University, London, ON, Canada.; St. Joseph's Health Care London, London, ON, Canada.
Cowan A; Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Sultan N; Division of Nephrology, Western University, London, ON, Canada.; London Health Sciences Centre, London, ON, Canada.
Clemens KK; Division of Endocrinology and Metabolism, Western University, London, ON, Canada. .; St. Joseph's Health Care London, London, ON, Canada. .; Department of Epidemiology and Biostatistics, Western University, London, ON, Canada. .; Lawson Health Research Institute, London, ON, Canada. .; ICES, Ontario, Canada. .
Pokaż więcej
Źródło :
Archives of osteoporosis [Arch Osteoporos] 2021 Jul 28; Vol. 16 (1), pp. 116. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/drug therapy
Renal Insufficiency, Chronic*/drug therapy
Bone Density ; Denosumab/adverse effects ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Evaluation of care delivery by a novel multidisciplinary bone health clinic for patients at risk of glucocorticoid-induced osteoporosis.
Autorzy :
Abdullah H; Faculty of Medicine, Department of Family Practice, University of British Columbia, Vancouver, BC, Canada.
Koller G; Department of Medicine, Division of Rheumatology, University of Alberta, 8-130 Clinical Sciences Building, 11350 83rd Avenue NW, Edmonton, AB, T6G 2G3, Canada.
Zuna I; Department of Medicine, Division of Rheumatology, University of Alberta, 8-130 Clinical Sciences Building, 11350 83rd Avenue NW, Edmonton, AB, T6G 2G3, Canada.
Yuksel N; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
Charrois T; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
Mandhane R; Alberta Health Services, University of Alberta Hospital, Edmonton, AB, Canada.
Cotton K; Alberta Health Services, University of Alberta Hospital, Edmonton, AB, Canada.
Danilak M; Alberta Health Services, University of Alberta Hospital, Edmonton, AB, Canada.
Bell H; Alberta Health Services, University of Alberta Hospital, Edmonton, AB, Canada.
Ye C; Department of Medicine, Division of Rheumatology, University of Alberta, 8-130 Clinical Sciences Building, 11350 83rd Avenue NW, Edmonton, AB, T6G 2G3, Canada. .
Pokaż więcej
Źródło :
Archives of osteoporosis [Arch Osteoporos] 2021 Jul 07; Vol. 16 (1), pp. 108. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/chemically induced
Osteoporosis*/drug therapy
Osteoporosis*/epidemiology
Osteoporotic Fractures*/chemically induced
Osteoporotic Fractures*/epidemiology
Osteoporotic Fractures*/prevention & control
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Bone Density ; Female ; Glucocorticoids/adverse effects ; Humans ; Middle Aged ; Prospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis: A 2-Year Randomized Study.
Autorzy :
Sølling AS; Department of Internal Medicine, Randers Regional Hospital, Randers, Denmark.; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Harsløf T; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Langdahl B; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Pokaż więcej
Źródło :
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2021 Jul; Vol. 36 (7), pp. 1245-1254. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*/drug therapy
Bone Density ; Denosumab/therapeutic use ; Female ; Humans ; Zoledronic Acid/therapeutic use
Czasopismo naukowe
Tytuł :
Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial.
Autorzy :
Papapoulos S; Leiden University Medical Center, Leiden, The Netherlands.
Bone H; Michigan Bone & Mineral Clinic, Detroit, MI, USA.
Cosman F; Columbia University, New York, NY, USA.
Dempster DW; Columbia University, New York, NY, USA.
McClung MR; Oregon Osteoporosis Center, Portland, OR, USA.; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
Nakamura T; University of Occupational and Environmental Health, Fukuoka, Japan.
Restrepo JFM; Reumalab, Medellín, Colombia.
Bouxsein ML; Center for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, and Department of Orthopedic Surgery, Harvard Medical School, Boston, MA, USA.
Cohn D; Merck & Co., Inc., Kenilworth, NJ, USA.
de Papp A; Merck & Co., Inc., Kenilworth, NJ, USA.
Massaad R; MSD Europe Inc., Brussels, Belgium.
Santora A; Merck & Co., Inc., Kenilworth, NJ, USA.
Pokaż więcej
Źródło :
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2021 Jul; Vol. 36 (7), pp. 1225-1234. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Hip Fractures*/drug therapy
Hip Fractures*/epidemiology
Osteoporosis*
Osteoporosis, Postmenopausal*/complications
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis, Postmenopausal*/epidemiology
Biphenyl Compounds ; Bone Density ; Double-Blind Method ; Female ; Femur Neck ; Humans ; Incidence ; Postmenopause
Czasopismo naukowe
Tytuł :
Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion.
Autorzy :
Anastasilakis AD; Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece. .
Polyzos SA; First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Yavropoulou MP; Endocrinology Unit, 1st Department of Propaedeutic and Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Ntenti C; First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Mandanas S; Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece.
Makras P; Department of Endocrinology and Diabetes and Department of Medical Research, 251 Hellenic Air Force & VA General Hospital, Athens, Greece.
Pokaż więcej
Źródło :
Endocrine [Endocrine] 2021 Jul; Vol. 73 (1), pp. 223-225. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Letter
MeSH Terms :
Bone Density Conservation Agents*
Osteoporosis, Postmenopausal*
Bone Density ; Denosumab ; Diphosphonates ; Female ; Humans ; Zoledronic Acid
Opinia redakcyjna
Tytuł :
Prevention of bone loss and improvement of pain-related behavior in hind limb-unloaded mice by administration of teriparatide and bisphosphonate.
Autorzy :
Miyamura G; Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie, Japan.
Wakabayashi H; Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie, Japan.
Nagao N; Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie, Japan.
Kato S; Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie, Japan.
Nakagawa T; Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie, Japan.
Naito Y; Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie, Japan.
Sudo A; Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie, Japan.
Pokaż więcej
Źródło :
Modern rheumatology [Mod Rheumatol] 2021 May; Vol. 31 (3), pp. 733-742. Date of Electronic Publication: 2020 Jul 10.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density*
Bone Density Conservation Agents/*therapeutic use
Diphosphonates/*therapeutic use
Osteoporosis/*drug therapy
Pain/*drug therapy
Teriparatide/*therapeutic use
Alendronate/administration & dosage ; Alendronate/therapeutic use ; Animals ; Bone Density Conservation Agents/administration & dosage ; Diphosphonates/administration & dosage ; Female ; Hindlimb Suspension/adverse effects ; Male ; Mice ; Osteoclasts/metabolism ; Osteoporosis/etiology ; Teriparatide/administration & dosage ; Tumor Necrosis Factor-alpha/metabolism ; X-Ray Microtomography
Czasopismo naukowe
Tytuł :
Bone targeting nanocarrier-assisted delivery of adenosine to combat osteoporotic bone loss.
Autorzy :
Hoque J; Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC, 27710, USA.
Shih YV; Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC, 27710, USA.
Zeng Y; Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC, 27710, USA; Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC, 27710, USA.
Newman H; Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC, 27710, USA.
Sangaj N; Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC, 27710, USA.
Arjunji N; Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC, 27710, USA.
Varghese S; Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC, 27710, USA; Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC, 27710, USA; Department of Biomedical Engineering, Duke University, Durham, NC, 27710, USA. Electronic address: .
Pokaż więcej
Źródło :
Biomaterials [Biomaterials] 2021 Jun; Vol. 273, pp. 120819. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Bone Density Conservation Agents*
Osteoporosis*/drug therapy
Adenosine ; Alendronate ; Animals ; Bone Density ; Bone and Bones ; Female ; Humans ; Mice ; Ovariectomy ; Rats ; Rats, Sprague-Dawley ; X-Ray Microtomography
Czasopismo naukowe
Tytuł :
The efficacy and safety of bisphosphonate analogs for treatment of osteoporosis after spinal cord injury: a systematic review and meta-analysis of randomized controlled trials.
Autorzy :
Wu Y; School of Rehabilitation Medicine, Capital Medical University, Beijing, China.
Wang F; School of Rehabilitation Medicine, Capital Medical University, Beijing, China. .; Department of Spine and Spinal Cord Surgery, Beijing Bo'ai Hospital, China Rehabilitation Research Center, No. 10, Jiaomen North Road, Fengtai District, Beijing, China. .
Zhang Z; School of Rehabilitation Medicine, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło :
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2021 Jun; Vol. 32 (6), pp. 1117-1127. Date of Electronic Publication: 2021 Jan 02.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/drug therapy
Osteoporosis*/etiology
Spinal Cord Injuries*/complications
Bone Density ; Diphosphonates/adverse effects ; Humans ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density.
Autorzy :
Lyles KW; Duke University School of Medicine, Durham, NC, USA. .; GRECC, VA Medical Center, Durham, NC, USA. .
Bauer DC; University of California, San Francisco, San Francisco, CA, USA.; California Pacific Medical Center, San Francisco, CA, USA.
Colon-Emeric CS; Duke University School of Medicine, Durham, NC, USA.; GRECC, VA Medical Center, Durham, NC, USA.
Pieper CF; Duke University School of Medicine, Durham, NC, USA.
Cummings SR; University of California, San Francisco, San Francisco, CA, USA.; California Pacific Medical Center, San Francisco, CA, USA.
Black DM; University of California, San Francisco, San Francisco, CA, USA.; California Pacific Medical Center, San Francisco, CA, USA.
Pokaż więcej
Źródło :
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2021 Jun; Vol. 32 (6), pp. 1217-1219. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Hip Fractures*/prevention & control
Hip Fractures*/surgery
Bone Density ; Femur Neck/surgery ; Humans ; Zoledronic Acid/therapeutic use
Czasopismo naukowe
Tytuł :
Fracture rates in patients discontinuing alendronate treatment in real life: a population-based cohort study.
Autorzy :
Sølling AS; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark. .
Christensen DH; Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark.
Darvalics B; Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark.
Harsløf T; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.
Thomsen RW; Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark.
Langdahl B; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.
Pokaż więcej
Źródło :
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2021 Jun; Vol. 32 (6), pp. 1103-1115. Date of Electronic Publication: 2021 Jan 07.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/adverse effects
Osteoporosis, Postmenopausal*
Alendronate/therapeutic use ; Bone Density ; Cohort Studies ; Female ; Humans
Czasopismo naukowe
Tytuł :
Effect of lumbar spinal stenosis on bone mineral density in osteoporosis patients treated with ibandronate.
Autorzy :
Park HY; Department of Orthopedic Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, the Catholic University of Korea, 1021, Tongil-Ro, Eunpyeong-gu, 03312, Seoul, Republic of Korea.
Ha JY; Department of Orthopedic Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, the Catholic University of Korea, 1021, Tongil-Ro, Eunpyeong-gu, 03312, Seoul, Republic of Korea.
Kim KW; Department of Orthopedic Surgery, Yeouido St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Seoul, Korea.
Baek IH; Department of Orthopedic Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, the Catholic University of Korea, 1021, Tongil-Ro, Eunpyeong-gu, 03312, Seoul, Republic of Korea.
Park SB; Department of Orthopedic Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, the Catholic University of Korea, 1021, Tongil-Ro, Eunpyeong-gu, 03312, Seoul, Republic of Korea.
Lee JS; Department of Orthopedic Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, the Catholic University of Korea, 1021, Tongil-Ro, Eunpyeong-gu, 03312, Seoul, Republic of Korea. .
Pokaż więcej
Źródło :
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2021 May 04; Vol. 22 (1), pp. 412. Date of Electronic Publication: 2021 May 04.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Osteoporosis*/diagnostic imaging
Osteoporosis*/drug therapy
Osteoporosis*/epidemiology
Spinal Stenosis*/diagnostic imaging
Spinal Stenosis*/drug therapy
Bone Density ; Diphosphonates/therapeutic use ; Humans ; Ibandronic Acid ; Lumbar Vertebrae/diagnostic imaging ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Overview of treatment approaches to osteoporosis.
Autorzy :
Langdahl BL; Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Pokaż więcej
Źródło :
British journal of pharmacology [Br J Pharmacol] 2021 May; Vol. 178 (9), pp. 1891-1906. Date of Electronic Publication: 2020 Mar 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Osteoporosis*/drug therapy
Bone Density ; Diphosphonates ; Humans ; Osteogenesis
Czasopismo naukowe
Tytuł :
Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study Extension.
Autorzy :
Ramchand SK; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.; Department of Medicine, Endocrine Unit, Austin Hospital, The University of Melbourne, Heidelberg, VIC, Australia.
David NL; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Lee H; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.
Eastell R; Academic Unit of Bone Metabolism, University of Sheffield, Sheffield, UK.
Tsai JN; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Leder BZ; Department of Medicine, Endocrine Unit, Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Pokaż więcej
Źródło :
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2021 May; Vol. 36 (5), pp. 921-930. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Bone Density Conservation Agents*
Osteoporosis, Postmenopausal*/diagnostic imaging
Osteoporosis, Postmenopausal*/drug therapy
Bone Density ; Denosumab ; Female ; Femur Neck/diagnostic imaging ; Humans ; Teriparatide/pharmacology ; Zoledronic Acid
Czasopismo naukowe
Tytuł :
Real-world bone turnover marker use: impact on treatment decisions and fracture.
Autorzy :
Lane NE; Department of Internal Medicine, UC Davis Health, Sacramento, CA, USA. .
Saag K; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.
O'Neill TJ; Data Science and Services, Diagnostics Information Solutions, Roche Diagnostics, F. Hoffmann-La Roche, Belmont, CA, USA.
Manion M; Roche Diagnostics, Indianapolis, IN, USA.
Shah R; Data Science and Services, Diagnostics Information Solutions, Roche Diagnostics, F. Hoffmann-La Roche, Belmont, CA, USA.
Klause U; Roche Diabetes Care, Roche Diagnostics, Indianapolis, IN, USA.
Eastell R; Metabolic Bone Centre, Northern General Hospital, Sheffield, UK.
Pokaż więcej
Źródło :
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2021 May; Vol. 32 (5), pp. 831-840. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji :
Journal Article
MeSH Terms :
Bone Density Conservation Agents*/therapeutic use
Fractures, Bone*
Osteoporosis*/diagnosis
Osteoporosis*/drug therapy
Osteoporosis*/epidemiology
Aged ; Biomarkers ; Bone Density ; Bone Remodeling ; Humans ; Medicare ; Retrospective Studies ; United States/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies